CV Sciences, Inc.
(OOTC : CANV)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Are you a Dividend Trader
Learn how to make passive income from the best dividend stocks.
100% secure: your email is never shared, and you may opt out at any time.
...
Consumer Services » Other Consumer Services
symbolcompany%chnglast%shortavg$volume
PCLNPriceline Group Inc
-0.05%1760.003.2%$758.51m
EBAYeBay Inc.
2.05%38.371.6%$380.87m
EXPEExpedia, Inc.
0.82%120.886.8%$269.96m
CTRPCtrip.com International Ltd Sponsored ADR
1.01%44.014.6%$205.99m
EDUNew Oriental Education & Technology Group, Inc. Sponsored ADR
0.20%89.611.3%$123.87m
TRIPTripAdvisor, Inc.
1.57%35.0312.9%$120.84m
HRBH&R Block, Inc.
1.17%27.2111.0%$88.06m
WTWWeight Watchers International, Inc.
0.01%45.3415.2%$41.11m
SCIService Corporation International
-0.89%36.825.0%$34.41m
SERVServiceMaster Global Holdings Inc
4.99%52.154.8%$32.56m
PLNTPlanet Fitness Inc Class A
3.54%33.0211.8%$30.51m
ROLRollins, Inc.
2.45%46.824.0%$28.80m
LOPEGrand Canyon Education, Inc.
3.38%92.132.0%$19.73m
NTRINutrisystem, Inc.
3.91%51.803.6%$19.60m
BIDSotheby's Class A
1.49%51.1216.7%$16.00m

Company Profile

CV Sciences, Inc. is a life science company that develops, produces, markets and sells raw materials and end consumer products containing the hemp plant extract, Cannabidiol (CBD) to the nutraceutical, beauty care, pet care, specialty beverage and functional food sectors. The company operates through the following business segments: Specialty Pharmaceuticals and Consumer Products. The Specialty Pharmaceuticals segment is focused on developing and commercializing novel therapeutics utilizing synthetic Cannabidiol. The Consumer Products segment engages in the manufacturing, marketing and selling of plant-based CBD products. CV Sciences was founded by H. J. Cole, Michael J. Mona, Jr. and Michael J. Mona III on December 9, 2010 and is headquartered in Las Vegas, NV.